首页> 美国卫生研究院文献>Scientific Reports >Pareto Optimality Explanation of the Glycolytic Alternatives in Nature
【2h】

Pareto Optimality Explanation of the Glycolytic Alternatives in Nature

机译:自然界中糖酵解替代物的帕累托最优解释

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Entner-Doudoroff (ED) and Embden-Meyerhof-Parnas (EMP) glycolytic pathways are largely conserved across glycolytic species in nature. Is this a coincidence, convergent evolution or there exists a driving force towards either of the two pathway designs? We addressed this question by first employing a variant of the optStoic algorithm to exhaustively identify over 11,916 possible routes between glucose and pyruvate at different pre-determined stoichiometric yields of ATP. Subsequently, we analyzed the thermodynamic feasibility of all the pathways at physiological metabolite concentrations and quantified the protein cost of the feasible solutions. Pareto optimality analysis between energy efficiency and protein cost reveals that the naturally evolved ED and EMP pathways are indeed among the most protein cost-efficient pathways in their respective ATP yield categories and remain thermodynamically feasible across a wide range of ATP/ADP ratios and pathway intermediate metabolite concentration ranges. In contrast, pathways with higher ATP yield (>2) while feasible, are bound within stringent and often extreme operability ranges of cofactor and intermediate metabolite concentrations. The preponderance of EMP and ED is thus consistent with not only optimally balancing energy yield vs. enzyme cost but also with ensuring operability for wide metabolite concentration ranges and ATP/ADP ratios.
机译:Entner-Doudoroff(ED)和Embden-Meyerhof-Parnas(EMP)的糖酵解途径在自然界中在糖酵解物种中基本上是保守的。这是巧合,趋同的演变,还是存在两种途径设计的推动力?我们通过首先采用optStoic算法的变体来解决此问题,以不同的ATP预定化学计量产率详尽地鉴定了葡萄糖和丙酮酸之间的11,916条可能路线。随后,我们在生理代谢产物浓度下分析了所有途径的热力学可行性,并量化了可行解决方案的蛋白质成本。能源效率和蛋白质成本之间的帕累托最优分析表明,自然进化的ED和EMP途径确实是其各自ATP产量类别中最经济的途径之一,并且在各种ATP / ADP比和途径中间物上仍具有热力学可行性代谢物浓度范围。相反,具有较高ATP产量(> 2)的途径虽然可行,但在辅因子和中间代谢物浓度的严格且通常极端可操作性范围内绑定。因此,EMP和ED的优势不仅与能量收率相对于酶成本的最佳平衡相一致,而且与确保在宽的代谢物浓度范围和ATP / ADP比方面的可操作性相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号